Friday, November 11, 2011
Adolor Corp., of Exton, Pa., reported third quarter sales of $7.8 million for post-bowel surgery drug Entereg (alvimopan), a 20 percent increase over the third quarter last year, but a quarter-over-quarter decrease.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.